-
IWP-2: From Wnt Biology to Translational Strategy
2026-09-09
A mechanistic and strategic guide to using IWP-2 as a PORCN-directed Wnt production inhibitor, with implications for cancer research, assay design, and hypothesis-driven neurodevelopmental studies.
-
GSK 2837808A: A Flux-First LDHA Assay Strategy
2026-09-09
GSK 2837808A is a potent lactate dehydrogenase A inhibitor for dissecting lactate flux, glucose consumption reduction, and metabolic signaling in cancer models. This article provides a flux-first assay framework that connects validated hepatocellular carcinoma findings with carefully bounded, hypothesis-generating studies of lactate–immune biology.
-
Tyrothricin: Applied Antimicrobial Workflows
2026-09-08
Tyrothricin is a peptide antibiotic mixture suited to mechanism-focused bacterial and fungal assays, especially when membrane disruption must be connected to loss of viability. This guide translates the compound into practical workflows with fresh-solution handling, orthogonal readouts, assay controls, and troubleshooting strategies for reproducible antimicrobial research.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-07
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit (SKU K4136) is intended for higher-resolution protein electrophoresis and peptide separation in the low-molecular-weight range, including targets that are difficult to resolve with conventional Tris-SDS-PAGE. It is for scientific research workflows only and should not be used for diagnostic, clinical, or medical testing.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-09-07
The reference study challenges the prevailing view that AMPK universally promotes autophagy during glucose starvation, showing instead that AMPK suppresses ULK1 signaling while preserving the autophagy machinery during severe energy stress. These findings refine interpretation of pharmacological AMPK activation and support experimentally separating immediate autophagy induction from longer-term cellular recovery.
-
CTP Solution: Enabling Translational mRNA Therapy
2026-09-05
Translational mRNA programs depend on more than delivery technology. This article connects CTP chemistry and reagent quality with the mechanistic and development lessons of intravesical p21 mRNA–LNP therapy for bladder cancer, while outlining practical safeguards for reproducible in vitro transcription and preclinical translation.
-
5-HT3 Antagonists and Renal OCT2/MATE1 Inhibition
2026-09-05
George and colleagues systematically compared five 5-HT3 antagonists for their ability to inhibit OCT2- and MATE1-mediated organic cation transport in cellular models. The study identifies transporter-specific differences in potency and shows why antiemetic exposure may be relevant to renal drug–drug interaction research, while remaining an in vitro mechanistic investigation.
-
Danazol: From Steroid Signaling to Puberty Models
2026-09-04
Danazol research extends beyond steroidogenesis assays: this article explains how receptor activity, hypothalamic–pituitary–gonadal regulation, and rat puberty models can be interpreted together. It also translates the 2025 EHEC study into practical decisions for endocrine and prostate cancer research.
-
2% Phosphotungstic Acid Negative Stain Guide
2026-09-04
Phosphotungstic Acid Negative Stain Solution (2%) is a ready-to-use electron microscopy reagent for high-contrast imaging of biological specimens. It supports morphology-focused analysis of viruses, macromolecules, bacteria, and other particles, but it does not independently identify coronavirus glycan sites or prove lectin binding.
-
Artesunate Workflows for Cancer Cell-Death Assays
2026-09-03
Artesunate supports more than a single viability readout: it enables time-resolved comparison of growth inhibition, cell killing, ferroptosis-associated responses, and AKT/mTOR pathway changes. This practical workflow helps researchers deploy SKU B3662 in small cell lung carcinoma research and esophageal squamous cell carcinoma models while avoiding common solvent, timing, and interpretation errors.
-
JC-1 Mitochondrial Membrane Potential Assay
2026-09-02
A scenario-based guide to using the JC-1 Mitochondrial Membrane Potential Assay Kit, SKU K2002, for mitochondrial function analysis, apoptosis assay design, and cell apoptosis detection. It explains controls, sample compatibility, storage, ratio-based interpretation, and practical vendor-selection criteria.
-
Dutasteride: Applied Workflow for Prostate Research
2026-09-02
Dutasteride is a dual 5-alpha-reductase inhibitor for connecting testosterone-to-DHT biology with proliferation and apoptosis readouts. This practical guide covers stock preparation, cell-based workflows, assay controls, and a careful extension to cell–metabolite research inspired by a recent liver ischemia–reperfusion study.
-
Tofacitinib in RA Macrophage Assays
2026-09-01
Tofacitinib (CP-690550) offers a practical way to connect JAK/STAT pathway inhibition with macrophage phenotype, cytokine output, and mitochondrial recovery. This workflow helps distinguish true immune reprogramming from nonspecific cytotoxicity in GM-CSF-driven rheumatoid arthritis models.
-
S63845 MCL1 Inhibitor: Apoptosis Workflow
2026-09-01
Build a mechanism-first S63845 workflow that distinguishes MCL1 dependence from nonspecific cytotoxicity. The approach connects viability screening with BAX/BAK-dependent apoptosis, mitochondrial readouts, and senescence-focused residual-disease models.
-
IBDV VP3 Disrupts IRF7 Antiviral Signaling
2026-08-31
A 2025 Frontiers study identifies an immune-evasion mechanism in which infectious bursal disease virus VP3 interacts with IRF7 and promotes its proteasome-associated loss, weakening type I interferon signaling. The findings connect viral replication with selective disruption of chicken antiviral defense and provide a framework for testing how protein-stability pathways influence IBDV infection.